[1]冯 君,刘建和,冉俊宁,等.从痰、瘀、虚探讨动脉粥样硬化的中西医病机*[J].陕西中医,2020,(2):217-219.
　FENG Jun,LIU Jianhe,RAN Junning,et al.Discussion on the pathogenesis of atherosclerosis from phlegm,blood stasis and asthenia[J].,2020,(2):217-219.
点击复制

从痰、瘀、虚探讨动脉粥样硬化的中西医病机*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年2期
页码:
217-219
栏目:
学术探讨
出版日期:
2020-02-05

文章信息/Info

Title:
Discussion on the pathogenesis of atherosclerosis from phlegm,blood stasis and asthenia
文章编号:
DOI:〖HT5K〗10.3969/j.issn.10007369.2020.02.021
作者:
冯 君1; 刘建和1; 冉俊宁2; 吴源陶1 △
1.湖南中医药大学第一附属医院(长沙410007); 2.湖南中医药大学(长沙 410208)
Author(s):
FENG Jun; LIU Jianhe; RAN Junning; et al.
The First Hospital of Hunan University of Chinese Medicine(Changsha 410007)
关键词:
动脉粥样硬化;  痰;  瘀;  虚;  胸痹;  炎症反应
Keywords:
Atherosclerosis;  Phlegm;  Blood stasis;  Asthenia;  Chest apoplexy;  Inflammatory reaction
分类号:
R541.4
文献标志码:
A
摘要:
中医无动脉粥样硬化相对应病名,常归属于“胸痹”、“心痛”、“真心痛”、“中风”等范畴,其病机以痰、瘀、虚为主。现代医学研究表明,动脉粥样斑块的形成和发展过程始终伴随着炎症反应及其诱发的细胞坏死,而炎症反应与中医的痰、瘀、虚存在紧密的联系。以“虚”是炎症产生的根本,“痰瘀”是炎症激发和加剧的条件,痰瘀为标,互为因果,恶性循环的理论为指导,从痰、瘀、虚与炎症的关系,进一步探讨动脉粥样硬化的中西医病机,并结合最新研究发现,如清道夫受体内陷导致胆固醇逆转运异常、清道夫受体同时可介导低密度脂蛋白进入血管内皮、巨噬细胞转化为泡沫细胞、激活炎症通路诱发血管慢性炎症持续状态和激活细胞坏死相关通路诱发细胞坏死,最终引起动脉粥样硬化的发生和进展,为临床认识动脉粥样硬化的病机提供理论依据,有助于拓展临床对于动脉粥样硬化相关疾病的诊疗思路。
Abstract:
TCM has no corresponding disease name of atherosclerosis,which is often classified as “chest apoplexy”,“heartache”,“true pain” and “stroke”.Its pathogenesis is mainly phlegm,blood stasis and deficiency.Modern medical studies have shown that the formation and development of atherosclerotic plaque is always accompanied by inflammatory response and cell necrosis induced by it,and inflammatory response is closely related to phlegm,blood stasis and deficiency in TCM.With “virtual” produce inflammation is fundamental,“phlegm and blood stasis” is a condition of inflammation,stimulate and aggravate,phlegm and blood stasis as the standard,causal,vicious cycle theory as the instruction,the relationship between phlegm,blood stasis,deficiency and inflammation,and further explore the pathogenesis of Chinese and western medicine of atherosclerosis,and combined with a new study has found that,as a scavenger receptor invagination of scavenger receptor leads to abnormal reverse cholesterol transport,at the same time can be mediated low density lipoprotein into the vascular endothelium,macrophages into foam cells,activation of inflammation induced vascular chronic inflammatory state and activation and cell death pathways induced cell necrosis resulting in the occurrence and progress of atherosclerosis,It provides theoretical basis for clinical understanding of the pathogenesis of atherosclerosis and helps to expand clinical thinking for diagnosis and treatment of atherosis-related diseases.

参考文献/References:

[1] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[2] 俞 奇,王 斌,王 焱,等.我国2002-2016年间急性心肌梗死死亡趋势分析[J].中华疾病控制杂志,2019,23(1):5-9,28.
[3] Wang D,Wang Z,Zhang L,et al.Roles of cells from the arterial vessel wall in atherosclerosis[J].Mediators Inflamm,2017, 8135934.
[4] Marques PE,Nyegaard S,Collins RF,et al.Multimerization and retention of the scavenger receptor sr-b1 in the plasma membrane[J].Dev Cell,2019,50(3):283-295.
[5] Huang L,Chambliss KL,Gao X,et al.SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis[J].Nature,2019,569(7757):565-569.
[6] Back M,Yurdagul A Jr,Tabas I,et al.Inflammation and its resolution in atherosclerosis:mediators and therapeutic opportunities[J].Nat Rev Cardiol,2019,16(7):389-406.
[7] Tabas I,Lichtman AH.Monocyte-macrophages and T Cells in atherosclerosis[J].Immunity,2017,47(4):621-634.
[8] Dhuriya YK,Sharma D.Necroptosis:a regulated inflammatory mode of cell death[J].J Neuroinflammation,2018,15(1):199.
[9] Lin J,Li H,Yang M,et al.A role of RIP3-mediated macrophage necrosis in atherosclerosis development[J].Cell Rep,2013,3(1):200-210.
[10] Seimon TA,Nadolski MJ,Liao X,et al.Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress[J].Cell Metab,2010,12(5):467-482.
[11] Karunakaran D,Geoffrion M,Wei L,et al.Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis[J].Sci Adv,2016,2(7):e1600224.
[12] Wang Y,Ning X,Gao P,et al.Inflammasome activation triggers caspase-1-mediated cleavage of cGAS to regulate responses to DNA virus infection[J].Immunity,2017,46(3):393-404.
[13] Xie M,Yu Y,Kang R,et al.PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation[J].Nat Commun,2016,713280.
[14] 魏东生,邵 卫,张忠文,等.归脾汤联合复方银杏通脉口服液治疗老年脑动脉粥样硬化临床研究[J].陕西中医,2017,38(8):1106-1107.
[15] Conrad M,Angeli JP,Vandenabeele P,et al.Regulated necrosis:disease relevance and therapeutic opportunities[J].Nat Rev Drug Discov,2016,15(5):348-366.
[16] 马春香,孙 媛,陈晓斌,等.丹参酮ⅡA预处理对心肌缺血再灌注损伤保护作用的研究[J].陕西医学杂志,2017,46(10):1358-1359.

相似文献/References:

[1]王清亮,陆文杰,陈咸川.益气活血化痰通络方对颈动脉粥样硬化患者T细胞亚群影响的研究[J].陕西中医,2019,(3):307.
　WANG Qingliang,LU Wenjie,CHEN Xianchuan..Effect of Yiqi Huoxue Huatan Tongluo formula on Tcells subset in patients with carotid atherosclerosis[J].,2019,(2):307.
[2]陈 静,陈 炜,伍 媛,等.小续命汤及其组分治疗急性脑梗死研究进展*[J].陕西中医,2019,(12):1818.
[3]秦 魏,邢 露,杨智慧,等.丹参活性成分在抗动脉粥样硬化中的作用与机制研究进展[J].陕西中医,2021,(7):977.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.044]
[4]蔡 婉,周 华,葛 文,等.清脂化瘀颗粒调控Keap-1/Nrf2/ARE介导的氧化损伤抗动脉粥样硬化的作用及机制研究[J].陕西中医,2022,(2):166.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.006]
　CAI Wan,ZHOU Hua,GE Wen,et al.Effect and mechanism of Qingzhi Huayu granule on regulating Keap-1/Nrf2/ARE mediated oxidative damage and anti atherosclerosis[J].,2022,(2):166.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.006]
[5]许 辉,仇 杰,陈 中,等.仇湘中从“虚、瘀、痰”论治老年性膝骨关节炎经验[J].陕西中医,2022,(9):1272.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.030]
　XU Hui,QIU Jie,CHEN Zhong,et al.Qiu Xiangzhong's experience in treating senile knee osteoarthritis from “Xu Yu Tan”[J].,2022,(2):1272.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.030]
[6]陈抒鹏,王思梦,唐娜娜,等.基于浊邪与铁死亡相关性探析动脉粥样硬化之病机[J].陕西中医,2022,(11):1589.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.023]
　CHEN Shupeng,WANG Simeng,TANG Nana,et al.Exploring the pathogenesis of atherosclerosis based on the correlation between turbid pathogens and ferroptosis[J].,2022,(2):1589.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.023]
[7]张 涛,丁 宁,罗 吉,等.从痰刍议腺瘤性结直肠息肉的论治[J].陕西中医,2022,(11):1596.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.025]
　ZHANG Tao,DING Ning,LUO Ji,et al.Discussion on the treatment of adenomatous colorectal polyp based on “phlegm”[J].,2022,(2):1596.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.025]
[8]Nguyen Xuan Huynh(越南),梁 硕,孟 毅,等.益气活血清热解毒方治疗动脉粥样硬化临床研究[J].陕西中医,2023,(6):746.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.014]
　Nguyen Xuan Huynh,LIANG Shuo,MENG Yi,et al.Clinical study of Yiqi Huoxue Qingre Jiedu recipe in the treatment of atherosclerosis[J].,2023,(2):746.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.014]
[9]黄昌锐,李汶珊,袁 惠,等.护心康片对动脉粥样硬化小鼠自噬干预机制[J].陕西中医,2023,(7):854.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.006]
　HUANG Changrui,LI Wenshan,YUAN Hui,et al.Intervention mechanism of cardiac protection tablets on autophagy in atherosclerotic mice[J].,2023,(2):854.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.006]
[10]迟显苏,梁 晓,魏竞竞,等.基于血浊理论从痰、瘀、毒论治缺血性脑卒中[J].陕西中医,2023,(7):917.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.021]
　CHI Xiansu,LIANG Xiao,WEI Jingjing,et al.Treatment of ischemic stroke from perspective of phlegm blood stasis and poison based on theory of turbid blood[J].,2023,(2):917.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.021]

备注/Memo

备注/Memo:
*湖南省教育厅一般项目(18C0366)
更新日期/Last Update: 2020-03-31